Louise M Burrell

Loading... 2 0 20 0 false
Credit Name
Louise M Burrell
Full Name
Burrell, Louise M
 
Title
Prof
 
 
Twitter
Loading... 3 0 20 0 false

Publications

Results 141-160 of 179 (Search time: 0.013 seconds).

Publication YearTitleAuthor(s)
1411-Dec-2000Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.Burrell, Louise M ; Farina, N K; Balding, Leanne C; Johnston, Colin I
1421-Oct-2000Antihypertensive and antihypertrophic effects of omapatrilat in SHR.Burrell, Louise M ; Droogh, J; Man in't Veld, O; Rockell, M D; Farina, N K; Johnston, Colin I
1431-Jun-2000Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.Farina, N K; Johnston, Colin I; Burrell, Louise M 
1441-Mar-2000Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertension.Burrell, Louise M ; Risvanis, John; Johnston, Colin I; Naitoh, M; Balding, Leanne C
1451-Dec-1999Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy.Power, JM; Raman, Jai S ; Dornom, A; Farish, S J; Burrell, Louise M ; Tonkin, Andrew M; Buxton, Brian F ; Alferness, Clif A
14617-Sep-1999In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat.Risvanis, John; Naitoh, M; Johnston, Colin I; Burrell, Louise M 
1471-May-1999Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction.Dean, Rachael G; Edmondson, S R; Burrell, Louise M ; Bach, Leon A
1488-Dec-1998Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats.Yu, H C; Burrell, Louise M ; Black, M Jane; Wu, L L; Dilley, R J; Cooper, Mark E; Johnston, Colin I
1491-Oct-1998Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.Tikkanen, T; Tikkanen, Ilkka; Rockell, M D; Allen, Terri J; Johnston, Colin I; Cooper, Mark E; Burrell, Louise M 
1501-Jul-1998Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.Burrell, Louise M ; Phillips, P A; Risvanis, John; Chan, Robert K ; Aldred, K L; Johnston, Colin I
15116-May-1998New hormonal blockade strategies in cardiovascular disease.Johnston, Colin I; Naitoh, M; Risvanis, John; Farina, N K; Burrell, Louise M 
15216-May-1998Thirst in elderly subjects.Naitoh, M; Burrell, Louise M 
15316-May-1998Effects of chronic AVP V2R blockade in congestive heart failure in sheep. Comparison with chronic ACE inhibition.Naitoh, M; Power, JM; Phillips, P A; Risvanis, John; Johnston, Colin I; Burrell, Louise M 
1541-May-1998Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat.Risvanis, John; Johnston, Colin I; Phillips, P A; Burrell, Louise M 
1551-Apr-1998Susceptibility to atrial fibrillation: a study in an ovine model of pacing-induced early heart failure.Power, JM; Beacom, G A; Alferness, Clif A; Raman, Jai S ; Wijffels, M; Farish, S J; Burrell, Louise M ; Tonkin, Andrew M
1568-Jul-1997Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension.Burrell, Louise M ; Risvanis, John; Phillips, P A; Naitoh, M; Johnston, Colin I
1571-Jul-1997Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495.Burrell, Louise M ; Farina, N K; Risvanis, John; Woollard, D; Casely, D; Johnston, Colin I
1581-Jun-1997Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.Burrell, Louise M ; Johnston, Colin I
1591-Feb-1997Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR.Naitoh, M; Burrell, Louise M ; Risvanis, John; Aldred, K L; Rockell, M D; Johnston, Colin I; Phillips, P A
1601-Jan-1997A risk-benefit assessment of losartan potassium in the treatment of hypertension.Burrell, Louise M